Impact of a campaign on the public's attitudes towards depression

Health Education Research

Volumn 25, Issue 1, 2010, Pages 135-150

  Dietrich, Sandra ^a   Mergl, Roland ^a   Freudenberg, Philine ^b   Althaus, David ^c   Hegerl, Ulrich ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b ReSource the Counselling Centre Ltd Central   (Hong Kong)

^c Praxis Am Gröbenbach ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HEALTH EDUCATION; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; PUBLIC OPINION; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SOCIAL PSYCHOLOGY; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; AWARENESS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PREJUDICE; PRIMARY HEALTH CARE; PUBLIC OPINION; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 75649143234     PISSN: 02681153     EISSN: 14653648     Source Type: Journal    
DOI: 10.1093/her/cyp050     Document Type: Article

References (48)

1. World Health Organisation. Depression. Available at: http://www.who.int/ mental-health/management/depression/ definition/en/. Accessed: 6 March 2008.
2. Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol 2006; 100: 481-499
3. ten Doesschate MC, Koeter MWJ, Bockting CLH et al. Health related quality of life in recurrent depression: a comparison with a general population sample. J Affect Disord 2009; doi:10.1016/j.jad.2009.04.026, epub ahead of print, 13 May 2009.
4. Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry 1999; 56: 897-904.
5. Strine TW, Kroenke K, Dhingra S et al. The associations between depression, health-related quality of life, social support, life satisfaction, and disability in community-dwelling US adults. J Nerv Ment Dis 2009; 197: 61-64
6. Creed F, Morgan R, Fiddler M et al. Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 2002; 43: 302-309
7. Reed C, Monz BU, Perahia DGS et al. Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER. J Affect Disord 2009; 113: 296-302.
8. Bramesfeld A, Stoppe G. Einführung [Introduction]. In: Stoppe G, Bramesfeld A, Schwartz FM (eds). Volkskrankheit Depression? Bestandsaufnahme und Perspektiven [Depression-A Common Disease? Summary and Prospects]. Berlin, Heidelberg: Springer-Verlag, 2006, 1-12.
9. Luppa M, Heinrich S, Angermeyer MC et al. Cost-of-illness studies of depression: a systematic review. J Affect Disord 2007; 98: 29-43.
10. Stewart WF, Ricci JA, Chee E et al. Cost of lost productive work time among US workers with depression. JAMA 2003; 289: 3135-3144 (Pubitemid 37432889)
11. Sobocki P, Lekander I, Borgstroem F et al. The economic burden of depression in Sweden from 1997 to 2005. Eur Psychiatry 2007; 22: 146-152
12. Donohue JM, Pincus HA. Reducing the societal burden of depression. A review of economic costs, quality of care and effects of treatment. Pharmacoeconomics 2007; 25: 7-24.
13. Teh-Wei H. The economic burden of depression and reimbursement policy in the Asia Pacific region. Australas Psychiatry 2004; 12: S11-5.
14. Hawthorne G, Cheok F, Goldney R et al. The excess cost of depression in South Australia: a population-based study. Aust N Z J Psychiatry 2003; 37: 362-373
15. Greenberg PE, Kessler R, Birnbaum HG. Depression's costly toll. Behav Health Manage 2004; 24: 9-10.
16. Sobocki P, Jonsson B, Angst J et al. Cost of depression in Europe. J Ment Health Policy Econ 2006; 9: 87-98.
17. Friemel S, Bernert S, Angermeyer MC et al. Die direkten Kosten von depressiven Erkrankungen in Deutschland [The Direct Costs of Depressive Disorders in Germany Results from the European Study of the Epidemiology of Mental Disorders]. Psychiatr Prax 2005; 32: 113-121
18. Guenther OH, Friemel S, Bernert S et al. Die Krankheitslast von depressiven Erkrankungen in Deutschland. [The Burden of Depressive Disorders in Germany Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD)]. Psychiatr Prax 2007; 34: 292-301.
19. Kessler R, Berglund P, Bruce M et al. The prevalence and correlates of untreated serious mental illness. Health Serv Res 2001; 36: 987-1007.
20. Regier DA, Narrow WE, Rae DS et al. The de facto US mental and addictive disorders service system: epidemiological catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993; 50: 85-94.
21. Fernandez A, Haro JM, Martinez-Alonso Met al. Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry 2007; 190: 172-173
22. Powers R, Kniesner T, Croghan T. Psychotherapy and pharmacotherapy in depression. J Ment Health Policy Econ 2002; 5: 153-161
23. Feldman G. Cognitive and behavioral therapies for depression: overview, new directions, and practical recommendations for dissemination. Psychiatr Clin North Am 2007; 30: 39-50.
24. Carr A. Depression in young people: description, assessment and evidence-based treatment. Dev Neurorehabil 2007; 11: 3-15.
25. Wolf N, Hopko D. Psychosocial and pharmacological interventions for depressed adults in primary care: a critical review. Clin Psychol Rev 2008; 28: 131-161
26. Althaus D, Niklewski G, Schmidtke A et al. [Changes in the frequency of suicidal behaviour after a 2-year intervention campaign]. Nervenarzt 2007; 78: 272-282
27. Simon G, Fleck M, Lucas R et al. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004; 161: 1626-1634 (Pubitemid 39201460)
28. Jorm AF, Medway J, Christensen H et al. Attitudes towards people with depression: effects on the public's help-seeking and outcome when experiencing common psychiatric symptoms. Aust N Z J Psychiatry 2000; 34: 612-618
29. Link B, Phelan JC, Bresnahan M et al. Public conceptions of mental illness: labels, causes, dangerousness, and social distance. Am J Public Health Nations Health 1999; 89: 1328-1333
30. Angermeyer M, Beck M, Dietrich S et al. The stigma of mental illness: patients' anticipations and experiences. Int J Soc Psychiatry 2004; 50: 153-162 (Pubitemid 39076857)
31. Goldman L, Nielsen N, Champion H. Awareness, diagnosis, and treatment of depression. J Gen Intern Med 1999; 14: 569-580
32. Docherty J. Barriers to the diagnosis of depression in primary care. J Clin Psychiatry 1997; 58: 5-10.
33. Hirschfeld RM, Keller M, Panico S et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997; 277: 333-340 (Pubitemid 27045015)
34. Paykel ES, Hart D, Priest RG. Changes in public attitudes to depression during the Defeat Depression Campaign. Br J Psychiatry 1998; 173: 519-522
35. Rix S, Paykel ES, Lelliott P et al. Impact of a national campaign on GP education: an evaluation of the Defeat Depression Campaign. Br J Gen Pract 1999; 49: 99-102.
36. Jorm AF, Christensen H, Griffiths KM. The impact of beyondblue: the national depression initiative on the Australian public's recognition of depression and beliefs about treatments. Aust N Z J Psychiatry 2005; 39: 248-254
37. Hickie I. Can we reduce the burden of depression? The Australian experience with beyondblue: the national depression initiative. Australas Psychiatry 2004; 12: S38-46.
38. Pirkis J, Hickie I, Young L et al. An evaluation of beyondblue, Australia's national depression initiative. Int J Ment Health Promot 2005; 7: 35-53.
39. Hegerl U, Althaus D, Schmidtke A et al. The alliance against depression: 2-year evaluation of a community-based intervention to reduce suicidality. Psychol Med 2006; 36: 1225-1233
40. Hegerl U, Althaus D, Stefanek J. Public attitudes towards treatment of depression: effects of an information campaign. Pharmacopsychiatry 2003; 36: 288-291
41. Hegerl U, Wittman M, Arensman E et al. The European Alliance Against Depression (EAAD): a multifaceted, community-based action programme against depression and suicidality. World J Biol Psychiatry 2008; 9: 51-59
42. Hegerl U, Wittenburg L, Gottlebe K et al. The European Alliance Against Depression: a multilevel approach to the prevention of suicidal behavior. Psychiatr Serv 2009; 60: 596-599
43. Porst R. Ausschöpfungen bei sozialwissenschaftlichen Umfragen. Annäherung aus der ZUMA-Perspektive. [Response rates in social sciences surveys. Approaches from the ZUMA perspective.] 1993. ZUMAArbeitsbericht.
44. Porst R. Ausschöpfungen bei sozialwissenschaftlichen Umfragen. Die Sicht der Institute. [Response rates in social sciences surveys. From the perspective of institutions.] 1996. ZUMA-Arbeitsbericht.
45. Angermeyer MC, Matschinger H, Riedel Heller SG. Whom to ask for help in case of a mental disorder? Preferences of the lay public. Soc Psychiatry Psychiatr Epidemiol 1999; 34: 202-210
46. Angermeyer MC, Held T, Gortler D. [Pro and contra: psychotherapy and psychopharmacotherapy attitude of the public]. Psychother Psychosom Med Psychol 1993; 43: 286-292
47. Pfeiffer-Gerschel T. Changes in the prescription of antidepressants by practice-based physicians. Evaluation of the "Nuremberg Alliance Against Depression". Doctoral Thesis Unpublished 2007.
48. Trojan A, Legewie H. Nachhaltige Gesundheit und Entwicklung. [Sustainable health and development.]. Frankfurt: Verlag, 2001.VAS.